Patents by Inventor Morris C. Laster

Morris C. Laster has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-31 improves efficacy of macrophage-based adoptive cell therapy for cancer
    Patent number: 12030922
    Abstract: The present invention provides macrophages genetically modified to express IL-31 or both IL-31 and a chimeric antigen receptor (CAR) for treatment of cancer. It further provides methods for treatment of cancer comprising administration of IL-31 along with genetically unmodified macrophages or genetically modified to express a CAR.
    Type: Grant
    Filed: July 19, 2019
    Date of Patent: July 9, 2024
    Assignee: OncoHost Ltd.
    Inventor: Morris C. Laster
  • IL-31 Improves Efficacy of Macrophage-Based Adoptive Cell Therapy for Cancer
    Publication number: 20200062816
    Abstract: The present invention provides macrophages genetically modified to express IL-31 or both IL-31 and a chimeric antigen receptor (CAR) for treatment of cancer. It further provides methods for treatment of cancer comprising administration of IL-31 along with genetically unmodified macrophages or genetically modified to express a CAR.
    Type: Application
    Filed: July 19, 2019
    Publication date: February 27, 2020
    Applicant: OncoHost Ltd.
    Inventor: Morris C. Laster